April 2021—nRichDX launched its Revolution Semi-Automated Workflow powered by Eppendorf’s epMotion 5073 instrument for the extraction of cfDNA and ctDNA from plasma and urine for liquid-based assay development. The semiautomated workflow automates the Revolution protocol’s wash and elution steps and is designed to increase yield, sensitivity, and throughput.
The system enables extraction from batches of eight to 24 samples in as little as three hours with 20 minutes of hands-on time. Sample volumes range from 3 mL to 20 mL and recovery rates are 70 to 90 percent.
Other applications for CTCs, exosomes, infectious disease wastewater monitoring, RNA, and total cell-free nucleic acid are in development.
nRichDX, 949-341-1980